Literature DB >> 11175926

Psychopathology of alcoholics during withdrawal and early abstinence.

T Wetterling1, K Junghanns.   

Abstract

Epidemiologic surveys show a high lifetime co-morbidity with psychiatric disorders (e.g., depression and anxiety) in alcoholics. However, alcoholics frequently complained about psychopathologic symptoms, particularly during alcohol withdrawal. There is some evidence that symptomatology decreases spontaneously with prolonged abstinence. Thus, the question arises whether high levels of psychopathology could be accounted for by withdrawal effects. This study was aimed at examining the impact of the alcohol withdrawal severity (assessed by the AWS scale) on psychopathologic symptoms. The psychopathologic profile of 110 alcoholics as measured by the Symptom Checklist-90 revised (SCL-90-R) was compared to that of 253 patients with adjustment, anxiety or depressive disorders (according to ICD-10 criteria). No relationship between the severity of alcohol withdrawal and psychopathology could be found which might hint at two different neurobiological processes underlying these phenomena. The comparison with patients suffering from depression or anxiety disorders revealed that the global symptom severity of alcoholics undergoing withdrawal was similar, but recovery was achieved more rapidly than in the other groups. On the other hand, the self-rated psychopathologic symptom profile of alcoholics was rather similar to that of patients with adjustment disorders. While about one-quarter of the alcoholics reported severe psychopathology on admission, only about 10% showed symptomatology at discharge about three weeks later, predominantly depression or anxiety. These results underline the notion that much of the psychopathology described by alcoholics decreases within 2-3 weeks after withdrawal without specific treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11175926     DOI: 10.1016/s0924-9338(00)00519-8

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  5 in total

1.  Endogenous bufadienolide mediates pressor response to ethanol withdrawal in rats.

Authors:  Vladimir A Kashkin; Edwin E Zvartau; Olga V Fedorova; Yakov Y Bagrov; Edward G Lakatta; Alexei Y Bagrov
Journal:  Eur Neuropsychopharmacol       Date:  2007-08-01       Impact factor: 4.600

2.  Meta-analysis of depression and substance use among individuals with alcohol use disorders.

Authors:  Kenneth R Conner; Martin Pinquart; Stephanie A Gamble
Journal:  J Subst Abuse Treat       Date:  2009-01-15

3.  Supersensitive Kappa Opioid Receptors Promotes Ethanol Withdrawal-Related Behaviors and Reduce Dopamine Signaling in the Nucleus Accumbens.

Authors:  Jamie H Rose; Anushree N Karkhanis; Rong Chen; Dominic Gioia; Marcelo F Lopez; Howard C Becker; Brian A McCool; Sara R Jones
Journal:  Int J Neuropsychopharmacol       Date:  2016-04-29       Impact factor: 5.176

4.  Psychological changes in alcohol-dependent patients during a residential rehabilitation program.

Authors:  Ines Giorgi; Marcella Ottonello; Giovanni Vittadini; Giorgio Bertolotti
Journal:  Neuropsychiatr Dis Treat       Date:  2015-12-07       Impact factor: 2.570

5.  Effect of lockdown following COVID-19 pandemic on alcohol use and help-seeking behavior: Observations and insights from a sample of alcohol use disorder patients under treatment from a tertiary care center.

Authors:  Yatan Pal Singh Balhara; Swarndeep Singh; Parul Narang
Journal:  Psychiatry Clin Neurosci       Date:  2020-06-22       Impact factor: 12.145

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.